Clinical Trials Browser

Phase 3 × INDUSTRY × Metastatic Pancreatic Adenocarcinoma × Clear all

NCT01954992 2024-12-31

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Phase 3 Recruiting

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma